Impact of systematic lymphadenectomy at the time of interval debulking surgery on the survival of patients with advanced-stage epithelial ovarian carcinoma following neoadjuvant chemotherapy

被引：0
|
作者：
Nasioudis, Dimitrios [1 ]
Mastroyannis, Spyridon [1 ]
Latif, Nawar [1 ]
Haggerty, Ashley [1 ]
Cory, Lori [1 ]
Giuntoli, Robert [1 ]
Kim, Sarah [1 ]
Morgan, Mark [1 ]
Ko, Emily [1 ]
机构：
[1] Penn Med, Philadelphia, PA USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
344
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [1] Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection
    Nasioudis, Dimitrios
    Gysler, Stefan
    Latif, Nawar A.
    Giuntoli II, Robert L.
    Kim, Sarah H.
    Ko, Emily M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (07) : 969 - 974
  • [2] OPTIMAL DEBULKING FOLLOWING CHEMOTHERAPY OF ADVANCED-STAGE EPITHELIAL OVARIAN-CARCINOMA
    PIURA, B
    GLEZERMAN, M
    JOURNAL OF SURGICAL ONCOLOGY, 1989, 40 (04) : 237 - 240
  • [3] Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [4] PRIMARY DEBULKING SURGERY OR NEOADJUVANT CHEMOTHERAPY FOLLOWED BY INTERVAL DEBULKING SURGERY FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER?
    Mansouri, H.
    Zemni, I.
    Ben Safta, I.
    Achouri, L.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A120 - A120
  • [5] Debulking Surgery in Advanced Epithelial Ovarian Cancer: Interval or at the End of Neoadjuvant Chemotherapy?
    F. Cantu-de Leon, D.
    Gallardo-Alvarado, L.
    Salcedo-Hernandez, R.
    Ramirez, R.
    Perez-Montiel, D.
    Onate-Ocana, L.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S86 - S86
  • [6] The Effect of CA125 Nadir Level on Survival of Advanced-Stage Epithelial Ovarian Carcinoma after Interval Debulking Surgery
    Zeng, Jing
    Huang, Huizhen
    Shan, Ying
    Li, Yan
    Jin, Ying
    Pan, Lingya
    JOURNAL OF CANCER, 2017, 8 (17): : 3410 - 3415
  • [7] Impact of delay in adjuvant chemotherapy administration for patients with advanced-stage epithelial ovarian carcinoma undergoing primary debulking surgery with bowel resection
    Nasioudis, Dimitrios
    Byrne, Maureen
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Morgan, Mark
    Latif, Nawar
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S176 - S176
  • [8] Impact of residual disease at interval debulking surgery on patterns of recurrence among patients with advanced-stage epithelial ovarian cancer
    Greer, A. C.
    Gockley, A. A.
    Manning-Geist, B. L.
    Melamed, A.
    Berkowitz, R. S.
    Horowitz, N. S.
    del Carmen, M. G.
    Clark, R. M.
    Growdon, W. B.
    Worley, M. J., Jr.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 105 - 105
  • [9] Surgical approach for interval debulking after neoadjuvant chemotherapy for treatment of advanced-stage ovarian cancer
    Dugan, K. B.
    McNamara, B.
    Lu, L.
    Litkouhi, B.
    Azodi, M.
    Schwartz, P. E.
    Ratner, E. S.
    Menderes, G.
    Silasi, D. A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 152 - 152
  • [10] Neoadjuvant chemotherapy with interval debulking surgery versus chemotherapy alone for advanced epithelial ovarian cancer
    Khouri, Olivia
    Fazzari, Melissa
    Katcher, Arielle
    Nevadunsky, Nicole
    Fife, Alexander
    Isani, Sara
    Smotkin, David
    Kuo, Dennis Yi-Shin
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S209 - S210
12345